K Morikawa1, A Nakano, F Oseko
1First Department of Internal Medicine, Shimane Medical University, Izumo, Japan.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Natural killer (NK) cell activity is significantly reduced in acute myelogenous leukemia (AML) patients. This impairment stems from a decrease in CD11+ cells with large granular lymphocyte morphology, affecting both binding and killing functions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: